BridgeMD
New treatment option for Systolic Heart Failure
Official title Neuromodulation of Inflammation and Endothelial Function
ClinicalTrials.gov ID: NCT05230732
What this study is testing
- What it's testing
- Heart failure with reduced ejection fraction (HFrEF) is a major cause of mortality in United States. Aging is a major risk factor for adverse outcomes associated with HFrEF, with majority of the patient's over the age of 50, continuing to experience symptoms, reduced exercise capacity and poor quality of life.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Systolic heart failure with EF \< or equal to 50%.
You likely can't join if
- patients in overt congestive heart failure / recent acute myocardial infarction (\< 4 weeks) or Unstable angina
- Active malignancy
- unilateral or bilateral vagotomy
- pregnant patients
- End stage liver disease
- history of recurrent vasovagal syncope, Sick sinus syndrome with no pacemaker, 2nd or 3rd degree AV block.
See the full eligibility criteria
- Systolic heart failure with EF \< or equal to 50%.
- patients in overt congestive heart failure / recent acute myocardial infarction (\< 4 weeks) or Unstable angina
- Active malignancy
- unilateral or bilateral vagotomy
- pregnant patients
- End stage liver disease
- history of recurrent vasovagal syncope, Sick sinus syndrome with no pacemaker, 2nd or 3rd degree AV block.
- Significant hypotension (Blood pressure \< 90 mm Hg) secondary to autonomic dysfunction
The study team makes the final eligibility decision.
Where it's taking place
- Oklahoma City, Oklahoma, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oklahoma City, Oklahoma, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.